Skip to main content

Originally from: Tennessee, USA 
Previous institutions: Purdue University 
Research interests: Cancer Biology, Immunology, Molecular Medicine

“I’m interested in exploring mechanisms of adaptive resistance to novel therapeutics, particularly in aggressive tumor models like PDAC, NSCLC, and CRC. I believe that transcriptional rebound mechanisms can be overpowered by the anti-tumor immune system, but the relationships among mechanisms of adaptive resistance and anti-tumor immune system dynamics have yet to be well elucidated. Thus, while I welcome the opportunity to explore both immune cell crosstalk and novel therapeutic efficacy, my hope is to identify a synergistic small-molecule/immunotherapy combo that can not only overcome adaptive resistance to single agent, but also translate well to the clinic.”